These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30690898)

  • 1. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness.
    Robertson OD; Coronado NG; Sethi R; Berk M; Dodd S
    Early Interv Psychiatry; 2019 Oct; 13(5):1032-1049. PubMed ID: 30690898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative neuroprotective agents in neuropsychiatric disorders.
    Dodd S; Maes M; Anderson G; Dean OM; Moylan S; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():135-45. PubMed ID: 23178231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
    Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
    Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Sink KM; Holden KF; Yaffe K
    JAMA; 2005 Feb; 293(5):596-608. PubMed ID: 15687315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight considerations in psychotropic drug prescribing and switching.
    Hasnain M; Vieweg WV
    Postgrad Med; 2013 Sep; 125(5):117-29. PubMed ID: 24113670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy.
    Sommerfeld-Klatta K; Jiers W; Rzepczyk S; Nowicki F; Łukasik-Głębocka M; Świderski P; Zielińska-Psuja B; Żaba Z; Żaba C
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of psychotropic drugs in Huntington's disease.
    Lauterbach EC
    Int J Mol Sci; 2013 Nov; 14(11):22558-603. PubMed ID: 24248060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics.
    Hill L; Lee KC
    Ann Pharmacother; 2013 Jan; 47(1):75-89. PubMed ID: 23341158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
    Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
    Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From neuroprogression to neuroprotection: implications for clinical care.
    Berk M; Conus P; Kapczinski F; Andreazza AC; Yücel M; Wood SJ; Pantelis C; Malhi GS; Dodd S; Bechdolf A; Amminger GP; Hickie IB; McGorry PD
    Med J Aust; 2010 Aug; 193(S4):S36-40. PubMed ID: 20712560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
    J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders?
    Soczynska JK; Kennedy SH; Chow CS; Woldeyohannes HO; Konarski JZ; McIntyre RS
    Expert Opin Investig Drugs; 2008 Jun; 17(6):827-43. PubMed ID: 18491985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological agents under research for the maintenance treatment in bipolar disorder.
    Dimitrakopoulos S; Konstantakopoulos G
    Psychiatriki; 2015; 26(3):169-80. PubMed ID: 26480221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotrophic and neuroprotective effects of psychotropic agents.
    Hunsberger J; Austin DR; Henter ID; Chen G
    Dialogues Clin Neurosci; 2009; 11(3):333-48. PubMed ID: 19877500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.